It had posted net profit of Rs 95.55 crore for the July- September period of the previous fiscal, GSK Pharma said in a BSE filing.
Standalone total income from the operations also rose to Rs 799.12 crore for the quarter under review as against Rs 717.53 crore for the same period a year ago.
GSK Pharma stock was trading 0.48 per cent lower at Rs 2,906.05 per scrip in the afternoon trade on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content